Stay updated on Nivolumab & Lenvatinib in HCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Lenvatinib in HCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added the hepatocellular carcinoma term and a Genetic and Rare Diseases Information Center resource; updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T22:44:46.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:43:06.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed older notices about government funding and NIH Clinical Center operating status. These are administrative updates that do not modify the study details.
    Difference
    0.4%
    Check dated 2026-02-11T09:24:51.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A new government funding notice was added to the page to inform users about potential updates and refer them to cc.nih.gov and opm.gov. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:35:39.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Minor UI and metadata updates, including Show glossary and small phrasing changes such as capitalization of 'Met QC Criteria'/'met QC Criteria' and 'No FEAR Act data', along with a new 'Revision: v3.4.0' note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:11:50.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4; no changes to the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:40:32.000Z thumbnail image

Stay in the know with updates to Nivolumab & Lenvatinib in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.